Literature DB >> 9712320

Cumulus expansion during in vitro maturation of bovine oocytes: relationship with intracellular glutathione level and its role on subsequent embryo development.

C C Furnus1, D G de Matos, D F Moses.   

Abstract

Glutamine (GLN) is a metabolic precursor for hexosamine synthesis and its inclusion in culture medium has been reported to improve cumulus expansion. Glutamine and cysteine share the same transport system. Excess external GLN may act as a competitive inhibitor for the uptake of cysteine and stimulate loss of cellular cysteine, interfering this with GSH synthesis. Experiments were designed to evaluate the effect of 1-3 mM GLN during in vitro maturation (IVM) on bovine-cumulus expansion, intracellular GSH levels in both oocytes and cumulus cells, and subsequent embryo development up to blastocyst stage. Also, GSH content was measured in 6- to 8-cell embryos and a possible relationship between cumulus expansion and GSH synthesis was studied. Intact cumulus cell-oocyte complexes were incubated for 24 hr and cumulus expansion was measured by a computerized image-digitizing system either before or after IVM. IVM/IVF bovine oocytes were cultured up to 6- to 8-cell stage embryos for assessment of GSH content or for 8 days up to blastocyst stage for embryo development. The measurement of total GSH content was performed by an enzymatic method in oocytes, cumulus cells and 6- to 8-cell embryos. The maximal expansion was achieved by addition of 2 mM GLN without affecting GSH levels, in both oocytes and cumulus cells. At 3 mM, the degree of cumulus expansion was lower and the GSH levels decreased. The addition of 2 mM GLN improves cleavage and blastocyst rates, whereas no differences were found between O, 1, and 3 mM GLN. Moreover, the GSH content in 6- to 8-cell embryos was similar at any GLN concentrations. In order to study the relationship between GSH and cumulus expansion: 6-diazo-5-oxo-1-norleucine (DON), an inhibitor of hexosamine synthesis, or buthionine sulfoximide (BSO), an inhibitor of GSH synthesis, either alone or with GLN was added to IVM medium. GSH level was not affected by the presence of DON. However, the degree of cumulus expansion was reduced in the presence of BSO. In conclusion, bovine oocytes matured in the presence of 2 mM GLN improve their capacity for subsequent embryo development. Nevertheless, GSH level was altered when GLN was added to IVM medium at a high concentration with a reduction in the degree of cumulus expansion. This study provides evidence that optimal cumulus expansion in vitro is partially dependent on hexosamine production and intracellular GSH content.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712320     DOI: 10.1002/(SICI)1098-2795(199809)51:1<76::AID-MRD9>3.0.CO;2-T

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  14 in total

1.  In vitro developmental potential of macaque oocytes, derived from unstimulated ovaries, following maturation in the presence of glutathione ethyl ester.

Authors:  E C Curnow; J P Ryan; D M Saunders; E S Hayes
Journal:  Hum Reprod       Date:  2010-08-20       Impact factor: 6.918

Review 2.  Oxidative stress and antioxidants: exposure and impact on female fertility.

Authors:  Elizabeth H Ruder; Terryl J Hartman; Jeffrey Blumberg; Marlene B Goldman
Journal:  Hum Reprod Update       Date:  2008-06-04       Impact factor: 15.610

3.  Sperm Redox System Equilibrium: Implications for Fertilization and Male Fertility.

Authors:  Lauren E Hamilton; Richard Oko; Antonio Miranda-Vizuete; Peter Sutovsky
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Excessive follicle-stimulating hormone during ovarian stimulation of cattle may induce premature luteinization of most ovulatory-size follicles†.

Authors:  Zaramasina L Clark; Kaitlin R Karl; Meghan L Ruebel; Keith E Latham; James J Ireland
Journal:  Biol Reprod       Date:  2022-05-17       Impact factor: 4.161

5.  A Nuclear and Cytoplasmic Characterization of Bovine Oocytes Reveals That Cysteamine Partially Rescues the Embryo Development in a Model of Low Ovarian Reserve.

Authors:  Valentina Lodde; Alberto Maria Luciano; Giulia Musmeci; Ileana Miclea; Irene Tessaro; Mariella Aru; David F Albertini; Federica Franciosi
Journal:  Animals (Basel)       Date:  2021-06-29       Impact factor: 2.752

Review 6.  Oocyte Selection for In Vitro Embryo Production in Bovine Species: Noninvasive Approaches for New Challenges of Oocyte Competence.

Authors:  Luis Aguila; Favian Treulen; Jacinthe Therrien; Ricardo Felmer; Martha Valdivia; Lawrence C Smith
Journal:  Animals (Basel)       Date:  2020-11-24       Impact factor: 2.752

7.  Developmental potential of prepubertal mouse oocytes is compromised due mainly to their impaired synthesis of glutathione.

Authors:  Guang-Zhong Jiao; Xin-Yan Cao; Wei Cui; Hua-Yu Lian; Yi-Long Miao; Xiu-Fen Wu; Dong Han; Jing-He Tan
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

8.  Cumulus expansion, nuclear maturation and connexin 43, cyclooxygenase-2 and FSH receptor mRNA expression in equine cumulus-oocyte complexes cultured in vitro in the presence of FSH and precursors for hyaluronic acid synthesis.

Authors:  Maria Elena Dell'Aquila; Maud Caillaud; Filippo Maritato; Alain Martoriati; Nadine Gérard; Giulio Aiudi; Paolo Minoia; Ghylène Goudet
Journal:  Reprod Biol Endocrinol       Date:  2004-06-22       Impact factor: 5.211

9.  Ascorbic acid improves the developmental competence of porcine oocytes after parthenogenetic activation and somatic cell nuclear transplantation.

Authors:  Michel Kere; Chawalit Siriboon; Neng-Wen Lo; Ngoc Tan Nguyen; Jyh-Cherng Ju
Journal:  J Reprod Dev       Date:  2012-11-15       Impact factor: 2.214

10.  Prostaglandin E2 affects in vitro maturation of bovine oocytes.

Authors:  Dorota Boruszewska; Ilona Kowalczyk-Zieba; Katarzyna Suwik; Joanna Staszkiewicz-Chodor; Joanna Jaworska; Krzysztof Lukaszuk; Izabela Woclawek-Potocka
Journal:  Reprod Biol Endocrinol       Date:  2020-05-11       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.